More Industrials stocks
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Veralto is a pure-play water quality and product identification/traceability company spun off from Danaher in October 2023. The company operates through two segments: Water Quality (~60% of revenue) providing treatment systems, testing equipment, and software for municipal/industrial water applications globally, and Product Quality & Innovation (~40%) offering marking, coding, and traceability solutions for food, beverage, and pharmaceutical packaging. The business benefits from Danaher Business System operational discipline, 60% gross margins, and recurring revenue from consumables/software.
Veralto employs a razor/razorblade model where equipment placements drive high-margin consumable sales (inks, reagents, test kits) and software subscriptions. Water Quality generates revenue from municipal infrastructure upgrades driven by regulatory compliance (PFAS, lead remediation) and industrial water reuse mandates. Product Quality monetizes food safety regulations requiring serialization/traceability. Pricing power stems from switching costs once equipment is integrated into production lines and regulatory-driven demand. The company leverages Danaher Business System for 200-300bps annual margin expansion through lean manufacturing and commercial excellence.
Water Quality segment organic growth driven by PFAS/PFOA remediation spending and EPA regulatory timelines for municipal water treatment upgrades
Product Quality consumable pull-through rates and equipment placements in food/beverage packaging lines, particularly in emerging markets
Margin expansion trajectory from Danaher Business System implementation and software/digital mix shift
M&A activity in fragmented water testing and serialization software markets where Veralto can deploy $1B+ in acquisition capacity
Municipal infrastructure spending tied to federal funding (IIJA, state revolving funds) and industrial capex cycles
Regulatory risk from potential delays or weakening of EPA PFAS standards and drinking water regulations that drive 15-20% of Water Quality demand; political shifts could slow municipal compliance timelines
Technology disruption in water testing from lower-cost sensor technologies and AI-driven predictive monitoring systems that could commoditize traditional lab equipment sales
Consolidation among food/beverage customers (Nestle, PepsiCo, AB InBev) increasing buyer negotiating power and pressuring Product Quality pricing on global supply agreements
Water Quality faces competition from Xylem, Pentair, and Evoqua (now Xylem) with overlapping municipal treatment portfolios and stronger installed base in certain geographies
Product Quality competes with Danaher-retained Videojet and independent players like Markem-Imaje (Dover) and Domino (Brother) in marking/coding, where technology parity reduces differentiation to service and consumable lock-in
Private equity-backed consolidators in fragmented water testing and serialization software markets could outbid Veralto for strategic acquisitions despite financial engineering disadvantages
Moderate leverage at 0.86x debt/equity provides $1-2B acquisition capacity but limits financial flexibility if organic growth decelerates below 4-5% and requires debt-funded M&A to meet growth targets
Pension and post-retirement obligations inherited from Danaher spin could create unfunded liability volatility if discount rates decline, though not disclosed as material in current filings
moderate - Water Quality (~60% of revenue) exhibits defensive characteristics tied to non-discretionary municipal water treatment and regulatory compliance, providing stability during downturns. Product Quality (~40%) has higher cyclical exposure to food/beverage/pharma production volumes and industrial capex spending. Overall revenue correlation to industrial production is approximately 0.4-0.5x, with geographic diversification (40% North America, 35% Europe, 25% high-growth markets) smoothing regional cycles.
Rising rates create headwinds through two channels: (1) municipal water utilities face higher borrowing costs for infrastructure projects, potentially delaying discretionary upgrades beyond regulatory-mandated spending, and (2) valuation multiple compression as investors rotate from high-quality industrials (trading 17-18x EBITDA) toward higher-yielding alternatives. However, limited direct debt refinancing risk given 0.86x debt/equity and investment-grade balance sheet. Customer financing costs matter more than Veralto's own cost of capital.
Minimal direct exposure - customer base spans investment-grade municipalities and large CPG/pharma companies with strong credit profiles. Accounts receivable risk is low given 60-day DSO and limited exposure to distressed end markets. Tightening credit conditions could delay large municipal water projects requiring bond issuance, but federal grant programs (IIJA allocating $55B for water infrastructure) provide non-debt funding backstop through 2026.
growth - Investors seek exposure to secular water infrastructure and food safety themes with 6-8% organic growth potential, 200-300bps annual margin expansion, and Danaher-pedigree operational execution. The stock attracts quality-focused growth investors willing to pay 17-18x EBITDA for defensive end-market exposure (60% Water Quality) balanced with higher-growth Product Quality. Recent 15% drawdown from highs creates entry point for long-term holders betting on multi-year PFAS remediation cycle and software mix shift driving 12-15% EPS growth.
moderate - As a recent spin-off (October 2023) with limited trading history, volatility is elevated versus mature industrials. Beta likely 1.0-1.2x given 40% exposure to cyclical Product Quality and industrial capex sensitivity. Quarterly earnings volatility stems from lumpy municipal project timing and geographic mix shifts. Defensive Water Quality characteristics and 60% gross margins provide downside support, but valuation premium (4.2x sales vs industrial peers at 2-3x) amplifies multiple compression risk in rate-driven selloffs.
